07:00 , Apr 27, 2015 |  BioCentury  |  Emerging Company Profile

Go-ing sugar specific

Go Therapeutics Inc. has developed a target discovery and screening platform that can generate mAbs against hybrid epitopes of cell surface proteins and aberrant O-linked glycosylation sites that are only found on tumors, resulting in...